Literature DB >> 2706176

Effect of halothane, enflurane and isoflurane on body temperature during and after surgery.

V Ramachandra1, C Moore, N Kaur, F Carli.   

Abstract

The superficial and deep body temperatures of 40 healthy females undergoing total abdominal hysterectomy were measured during surgery and for 4 h afterwards. The patients were allocated randomly to one of five groups and anaesthetized to produce an end-tidal concentration of 1% halothane, 1% enflurane, 2% enflurane, 1% isoflurane or 2% isoflurane. The patients received also 70% nitrous oxide in oxygen and neuromuscular blockade. The theatre temperature was maintained at 22.0 degrees C. There were significant body temperature changes during operation in all groups. The mean (SD) decrease in core temperature over 85 min was approximately 1.1 (0.3) degrees C in the 1% halothane, 2% enflurane and 2% isoflurane groups, and 0.6 (0.4) degrees C in the 1% enflurane and 1% isoflurane groups (P less than 0.05). During the recovery period the 1% halothane, 2% enflurane and 2% isoflurane groups took 2 h to rewarm to preoperative temperatures, and the rate of rewarming during this time was similar for all groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706176     DOI: 10.1093/bja/62.4.409

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Neurological examination in patients recovering from general anesthesia.

Authors:  F Fiacchino; M Gemma; M Bricchi; A Sghirlanzoni
Journal:  Ital J Neurol Sci       Date:  1992-12

2.  Effects of halothane and enflurane on the peripheral vasoconstriction and shivering induced by internal body cooling in rabbits.

Authors:  T Matsukawa; S Kashimoto; T Kumazawa; T Miyaji; M Hashimoto; M Iriki
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

3.  TRPA1 mediates the hypothermic action of acetaminophen.

Authors:  Clive Gentry; David A Andersson; Stuart Bevan
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.